Hung-Jyun Huang

Title: Innovator Profile: Hung-Jyun Huang

Introduction: Hung-Jyun Huang is an accomplished inventor based in Taipei, Taiwan, known for his significant contributions to the field of biotechnology. His work primarily focuses on developing innovative compounds aimed at treating various diseases through inhibition of receptor tyrosine kinases.

Latest Patents: Huang holds a notable patent titled "Quinoxaline compounds as type III receptor tyrosine kinase inhibitors." This patent describes a compound capable of inhibiting kinases, which play a crucial role in treating diseases or disorders mediated by such kinases. The structure of the compound includes a formula (I) or its stereoisomers, tautomers, or pharmaceutically acceptable salts. The compound shows potential in the treatment of diseases and conditions mediated by CSF-1R, c-KIT, FLT3, or PDGFR kinases, including cancers, autoimmune diseases, and bone resorptive diseases.

Career Highlights: Hung-Jyun Huang is associated with the Development Center for Biotechnology, where he actively participates in research and development. His innovative approaches in biochemistry and pharmacology have gained attention for their potential applications in medicine.

Collaborations: Throughout his career, Huang has collaborated with other distinguished professionals like Shao-Zheng Peng and Chu-Bin Liao. These collaborations have led to advancements in understanding and targeting receptor tyrosine kinases, furthering the field of targeted therapies.

Conclusion: Hung-Jyun Huang exemplifies the spirit of innovation within the biotechnology sector. His patent contributions and collaborative efforts with fellow researchers position him as a key player in the fight against diseases mediated by kinases, showcasing the critical role of inventors in advancing medical science.